XML 13 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income $ 387,859 $ 76,717
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 427,285 175,317
Impairment of long lived assets 27,727 5,731
Reduction in carrying value of operating right-of-use assets 35,238 30,607
Loss on equity method investments 2,643 1,471
Charge on interest rate hedge 0 891
Amortization of financing costs and debt discount 13,544 4,448
Stock compensation expense 55,703 114,791
Loss on extinguishment of debt 0 14,434
Deferred taxes (126,620) (26,532)
Unrealized foreign exchange gain (52,334) (7,374)
Loss on issuance of debt 0 59,460
Other non-cash items 18,595 (1,592)
Changes in operating assets and liabilities:    
Accounts receivable (140,760) 123,413
Unbilled revenue (221,104) 49,203
Unearned revenue 28,352 (60,514)
Other net assets 166,613 (21,147)
Net cash provided by operating activities 622,741 539,324
Cash flows from investing activities:    
Purchase of property, plant and equipment (85,145) (46,067)
Purchase of subsidiary undertakings, net of cash acquired 0 (5,914,475)
Purchase of equity method investment 0 (2,450)
Purchase of available for sale investments 0 17
Purchase of investments in equity - long term (1,840) (2,243)
Net cash used in investing activities (86,985) (5,965,218)
Cash flows from financing activities:    
Financing related costs 0 (30,349)
Proceeds from exercise of equity compensation 28,967 104,070
Share issue costs (3) (848)
Repurchase of ordinary shares (99,983) 0
Share repurchase costs (17) 0
Drawdown of bank credit lines and loan facilities 25,000 5,905,100
Repayment of bank credit lines and loan facilities (625,000) (377,780)
Net cash used in financing activities (671,036) 5,600,193
Effect of exchange rate movements on cash (7,775) (6,080)
Net (decrease)/ increase in cash and cash equivalents (143,055) 168,219
Cash and cash equivalents at beginning of period 752,213 840,305
Cash and cash equivalents at end of period $ 609,158 $ 1,008,524